Research programme: anticancer therapeutics - NovoBiotic PharmaceuticalsAlternative Names: Novo 10
Latest Information Update: 22 Jun 2016
At a glance
- Originator NovoBiotic Pharmaceuticals
- Class Macrocyclic compounds
- Mechanism of Action DNA modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Solid tumours
Most Recent Events
- 22 Jun 2016 Preclinical trials in Solid tumours in USA (unspecified route)